- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07705672
Role Of Fixed Prosthodontic Restorations on Metabolic Control of Ischemic Heart Disease Patients
July 10, 2026 updated by: Dr. Moaz Mohamed
Effect of Fixed Prosthodontic Rehabilitation on Nutritional and Metabolic Parameters in Patients With Ischemic Heart Disease
This study evaluated the effect of fixed prosthodontic rehabilitation on metabolic parameters and masticatory efficiency in patients with ischemic heart disease.
Clinical and laboratory outcomes was assessed before and after treatment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tanta, Egypt
- Faculty of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
inclusion criteria
- Patients aged 45 to 70 years with diagnosed stable ischemic heart disease.
- Patients presenting with partial edentulism and compromised masticatory function due to missing teeth.
- Patients indicated for fixed prosthodontic rehabilitation.
- Patients with complete clinical records and laboratory data available at baseline and 6 months after treatment.
- Patients who provided informed consent for treatment and use of their clinical data.
Exclusion criteria
- uncontrolled systemic diseases affecting metabolic status (e.g., uncontrolled diabetes mellitus).
- acute cardiovascular events or unstable ischemic heart disease.
- Patients with conditions affecting oral function other than tooth loss (e.g., neuromuscular disorders).
- Patients who received removable prostheses instead of fixed prosthodontic rehabilitation.
- Patients with incomplete clinical records or missing baseline or 6-month laboratory data.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Fixed Prosthodontic Rehabilitation
Placement of fixed prosthodontic restorations to replace missing teeth and improve masticatory function in patients with ischemic heart disease.
|
Placement of fixed prosthodontic restorations to replace missing teeth and improve masticatory function.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Hemoglobin A1c (HbA1c)
Time Frame: Baseline and 6 months after fixed prosthodontic rehabilitation
|
Hemoglobin A1c (HbA1c) (%) measured using standard laboratory methods.
The mean change in HbA1c from baseline to 6 months after fixed prosthodontic rehabilitation will be assessed.
|
Baseline and 6 months after fixed prosthodontic rehabilitation
|
|
Change in High-Density Lipoprotein Cholesterol (HDL-C)
Time Frame: Baseline and 6 months after fixed prosthodontic rehabilitation
|
High-density lipoprotein cholesterol (HDL-C) concentration (mg/dL) measured using standard laboratory blood analysis.
The mean change in HDL-C from baseline to 6 months after fixed prosthodontic rehabilitation will be assessed.
|
Baseline and 6 months after fixed prosthodontic rehabilitation
|
|
Change in Low-Density Lipoprotein Cholesterol (LDL-C)
Time Frame: Baseline and 6 months after fixed prosthodontic rehabilitation
|
Low-density lipoprotein cholesterol (LDL-C) concentration (mg/dL) measured using standard laboratory blood analysis.
The mean change in LDL-C from baseline to 6 months after fixed prosthodontic rehabilitation will be assessed.
|
Baseline and 6 months after fixed prosthodontic rehabilitation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2024
Primary Completion (Actual)
September 12, 2025
Study Completion (Actual)
November 30, 2025
Study Registration Dates
First Submitted
July 6, 2026
First Submitted That Met QC Criteria
July 10, 2026
First Posted (Actual)
July 15, 2026
Study Record Updates
Last Update Posted (Actual)
July 15, 2026
Last Update Submitted That Met QC Criteria
July 10, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Tanta-Dent-Cardio-2026-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemic Heart Disease
-
Elumn8 MedicalEnrolling by invitationIschemic Heart Disease | Ischemic Heart Disease Chronic | Coronary Chronic Total Occlusions | Ischemic Heart Disease (IHD)United States
-
Genzyme, a Sanofi CompanyTerminatedIschemic Heart Disease | Ischemic Cardiomyopathy | Ischemic Heart FailureBelgium, France, Germany, Italy, Switzerland, United Kingdom
-
University of AlbertaActive, not recruitingCoronary Artery Disease | Stable Ischemic Heart Disease | Beta-blocker TherapyCanada
-
Yonsei UniversityRecruitingIschemic Heart Diease | Non-ischemic Heart DiseaseSouth Korea
-
Cardiocentro TicinoTerminatedChronic Ischemic Heart DiseaseSwitzerland
-
Gerencia de Atención Primaria, MadridServicio Canario de Salud; Avedis Donabedian Research InstituteCompletedIschemic Heart Disease ChronicSpain
-
Michael SekelaCompletedChronic Ischemic Heart DiseaseUnited States
-
University of PecsCompleted
-
Zoll Medical CorporationRecruitingCardiovascular Diseases | Cardiomyopathies | Heart Disease, Ischemic | Cardiomyopathy IschemicGermany
-
Rigshospitalet, DenmarkNot yet recruitingChronic Ischemic Heart DiseaseDenmark
Clinical Trials on Fixed Prosthodontic Rehabilitation
-
Asan Medical CenterMinistry of Trade, Industry and Energy; Lifesemantics Corp.CompletedLung Cancer | COPD | Respiratory DiseaseKorea, Republic of
-
University of Roma La SapienzaCompletedEdentulous Patients
-
Raghda AlaaActive, not recruiting
-
Abbott Medical DevicesCompleted
-
University of SharjahCompletedWhite Spot Lesions | Proximal Caries | Plaque Removal | Oral Hygiene in Orthodontic PatientsUnited Arab Emirates
-
University of AthensActive, not recruitingRelapse | Orthodontic RetentionGreece
-
University Hospital, GhentCompleted
-
Indiana UniversityState University of New York at BuffaloCompletedHyperthermia | Kidney Injury | Dehydration | Kidney Dysfunction | Hot Weather; Adverse EffectUnited States
-
Mariam AlaaActive, not recruiting
-
University of OttawaCompletedTemperature Change, Body | Heat Stress | Temperature; Extreme, Exposure | Heat ExposureCanada